Australia Targets Patient Safety In Cell And Tissue Regulation Overhaul
Executive Summary
Proposed changes to the Australian rules on the therapeutic use of autologous cells and tissues, intended to address growing concerns over how they are processed and administered to patients, could result in changes to how such products are classified as well as to the general regulatory framework for cell and tissue products.